VEXIM announced that it has obtained the approval in Europe to extend the SpineJack system's CE Mark to all types of vertebral compression fractures.
The approval broadens VEXIM's potential market.
VEXIM is a medical device company focusing on the minimally invasive treatment of traumatic spinal pathologies.
More Articles on Devices:
New Developments in Knee Technology: ATTUNE® Rotating Platform & Anatomic Patella From DePuy Synthes Joint Reconstruction
Pain Management Devices Market in the U.S. to Reach Nearly $2.7B by 2022
Baxano Surgical Receives FDA 510(k) Clearance for Avance MIS Pedicle Screw System